tamsulosin has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Narayanan, NS; Schultz, J; Simmering, JE; Welsh, MJ | 1 |
| Liu, L; Narayanan, NS; Pottegård, A; Simmering, JE; Welsh, MJ | 1 |
2 other study(ies) available for tamsulosin and Parkinson Disease
| Article | Year |
|---|---|
Use of Glycolysis-Enhancing Drugs and Risk of Parkinson's Disease.
Topics: 5-alpha Reductase Inhibitors; Animals; Glycolysis; Humans; Male; Parkinson Disease; Prostatic Hyperplasia; Tamsulosin | 2022 |
Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cohort Studies; Databases, Factual; Denmark; Doxazosin; Female; Follow-Up Studies; Glycolysis; Humans; Male; Middle Aged; Parkinson Disease; Prazosin; Quinazolines; Registries; Risk Factors; Tamsulosin; United States | 2021 |